Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. (China)

Homepage: vaccine.com.cn

Alternate names: Beijing Luzhu Biopharmaceutical Co., Ltd., Beijing Zhifei Lvzhu Biopharmaceutical, Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd., Zhifei Lvzhu

ROR: 05ca4q118

OpenAlex ID: I4405268011

Safety and Immunogenicity of a Shigella Bivalent Conjugate Vaccine (ZF0901) in 3-Month- to 5-Year-Old Children in China

2021 · Yi Mo, Wenjian Fang, et al. · Vaccines · 33

PDF

Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics

2024 · Man Cui, Xiaohui Ji, et al. · Frontiers in Immunology · 28

PDF

From pathogenesis to antigens: the key to shaping the future of TB vaccines

2024 · Haoyan Yang, Xinkui Lei, et al. · Frontiers in Immunology · 16

PDF

Candidate Antigens and the Development of Helicobacter pylori Vaccines

2024 · Zhanhua Zhang, Man Cui, et al. · Helicobacter · 15

A multi-epitope vaccine incorporating adhesin-derived antigens protects against Mycobacterium tuberculosis infection and dissemination

2025 · Haoyan Yang, Xinkui Lei, et al. · Frontiers in Immunology · 4

PDF

Stopping Tuberculosis at the Gate: The Role of M. tuberculosis Adhesins in Infection and Intervention

2025 · Haoyan Yang, Yinuo Ma, et al. · Vaccines · 4

PDF

Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial

2022 · Lu-Lu Pan, Zhao Gao, et al. · Human Vaccines & Immunotherapeutics · 3

Research advances of the establishment and characterization of Helicobacter pylori infection animal models

2025 · Kaifang Zhang, Man Cui, et al. · Frontiers in Microbiology · 2

PDF

Quantification of Glycan in Glycoproteins via AUCAgent-Enhanced Analytical Ultracentrifugation

2026 · Xiaojuan Yu, Zhaoxing Wang, et al. · Pharmaceuticals · 1

PDF

Neisseria meningitidis serogroup X polysaccharide as a qualified antigen for multivalent meningococcal conjugate vaccines

2026 · Dan Fu, Kang Li, et al. · Frontiers in Immunology

PDF

Spatial ecology meets quality control: a GIS-integrated strategy for visualizing and managing microbial contamination in sterile pharmaceutical cleanrooms

2026 · Jiaji Wang, Pan Jiang, et al. · Microbiology Spectrum

A Phase III Clinical Trial of Immunogenicity and Safety of Meningococcal A and C Polysaccharide Conjugate Vaccine in Infants Aged 3–5 Months

2025 · Liwei Shi, Zhe Zhang, et al. · Vaccines

PDF

Enhanced Cobalt Tolerance of Saccharomyces cerevisiae by Engineering the Cytoprotection System

2025 · Y. Yang, G. Sun, et al. · Applied Biochemistry and Microbiology

A Single-Step Method for Harvesting Influenza Viral Particles from MDCK Cell Culture Supernatant with High Yield and Effective Impurity Removal

2024 · Sixu Liu, Jingqi Li, et al. · Viruses

A phase II, single-center, randomized, double-blind, parallel control clinical study evaluating the immunogenicity and safety of a two-dose schedule of serogroups ACYW meningococcal polysaccharide conjugate vaccine

2022 · Yi Mo, Yanan Li, et al. · Vaccine

Some reflections from the history of conjugate vaccine development

2013 · Du Li · Progress in Microbiology and Immunology

The establishment and validation of method for detecting residual cholera toxin in cholera vaccine

2011 · Dong Si-guo · Progress in Microbiology and Immunology

Works count: 17

Citation count: 470